| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Drug | 37 | 2005 | 57 | 5.300 |
Why?
|
| Blood Platelets | 26 | 2006 | 80 | 2.640 |
Why?
|
| Agmatine | 14 | 2013 | 17 | 2.080 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 18 | 2003 | 39 | 1.900 |
Why?
|
| Clonidine | 25 | 2005 | 52 | 1.850 |
Why?
|
| Depressive Disorder | 19 | 2006 | 185 | 1.810 |
Why?
|
| Imidazoline Receptors | 40 | 2006 | 41 | 1.680 |
Why?
|
| Neuroblastoma | 2 | 2022 | 134 | 1.370 |
Why?
|
| Imidazoles | 17 | 2005 | 138 | 1.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 9 | 2005 | 201 | 1.150 |
Why?
|
| Carrier Proteins | 9 | 2003 | 318 | 1.060 |
Why?
|
| Probiotics | 1 | 2022 | 37 | 0.750 |
Why?
|
| Brain | 12 | 2004 | 1452 | 0.740 |
Why?
|
| Depressive Disorder, Major | 4 | 2009 | 128 | 0.730 |
Why?
|
| Brassica | 1 | 2021 | 16 | 0.690 |
Why?
|
| Coculture Techniques | 1 | 2021 | 105 | 0.680 |
Why?
|
| Adrenergic alpha-Agonists | 9 | 2003 | 34 | 0.630 |
Why?
|
| Radioligand Assay | 18 | 2006 | 66 | 0.620 |
Why?
|
| Ureohydrolases | 2 | 2013 | 3 | 0.610 |
Why?
|
| Guanidines | 2 | 2013 | 18 | 0.610 |
Why?
|
| Brain Chemistry | 4 | 2003 | 140 | 0.590 |
Why?
|
| Receptors, Adrenergic, alpha | 8 | 1991 | 18 | 0.570 |
Why?
|
| Bupropion | 4 | 2002 | 13 | 0.550 |
Why?
|
| Antidepressive Agents, Second-Generation | 3 | 2009 | 6 | 0.530 |
Why?
|
| Neuroprotective Agents | 3 | 2013 | 267 | 0.530 |
Why?
|
| Animals | 50 | 2020 | 16695 | 0.490 |
Why?
|
| Antihypertensive Agents | 4 | 2005 | 285 | 0.450 |
Why?
|
| Desipramine | 7 | 2006 | 13 | 0.450 |
Why?
|
| Rats | 21 | 2020 | 3701 | 0.450 |
Why?
|
| Humans | 62 | 2022 | 42163 | 0.440 |
Why?
|
| Methoxyhydroxyphenylglycol | 5 | 1998 | 16 | 0.430 |
Why?
|
| Bipolar Disorder | 3 | 2011 | 83 | 0.430 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2013 | 44 | 0.430 |
Why?
|
| Binding Sites | 15 | 2003 | 670 | 0.410 |
Why?
|
| Down-Regulation | 7 | 2009 | 452 | 0.380 |
Why?
|
| Yohimbine | 7 | 2000 | 26 | 0.380 |
Why?
|
| Drug Discovery | 1 | 2013 | 106 | 0.380 |
Why?
|
| Piperazines | 1 | 2013 | 117 | 0.370 |
Why?
|
| Iodine Radioisotopes | 8 | 2003 | 39 | 0.370 |
Why?
|
| Adrenergic alpha-Antagonists | 5 | 2003 | 29 | 0.340 |
Why?
|
| Databases, Genetic | 1 | 2011 | 103 | 0.340 |
Why?
|
| Male | 38 | 2009 | 22779 | 0.330 |
Why?
|
| Antidepressive Agents | 3 | 2000 | 61 | 0.320 |
Why?
|
| Adult | 27 | 2009 | 13458 | 0.310 |
Why?
|
| Metallothionein | 8 | 1987 | 20 | 0.310 |
Why?
|
| Proteins | 4 | 2003 | 383 | 0.300 |
Why?
|
| Norepinephrine | 8 | 2006 | 110 | 0.300 |
Why?
|
| Cyclohexanols | 1 | 2009 | 7 | 0.300 |
Why?
|
| Epinephrine | 6 | 2003 | 37 | 0.300 |
Why?
|
| Imipramine | 3 | 1997 | 9 | 0.300 |
Why?
|
| Reference Values | 8 | 2009 | 207 | 0.290 |
Why?
|
| Middle Aged | 22 | 2009 | 11819 | 0.270 |
Why?
|
| Female | 38 | 2009 | 24018 | 0.270 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2013 | 1737 | 0.270 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 138 | 0.270 |
Why?
|
| Nitric Oxide Synthase | 3 | 2005 | 134 | 0.260 |
Why?
|
| Blood Pressure | 3 | 2003 | 662 | 0.260 |
Why?
|
| Protein Isoforms | 2 | 2003 | 139 | 0.250 |
Why?
|
| Amino Acid Motifs | 2 | 2003 | 94 | 0.250 |
Why?
|
| DNA, Complementary | 5 | 2004 | 195 | 0.240 |
Why?
|
| Zinc | 6 | 1987 | 130 | 0.240 |
Why?
|
| Medulla Oblongata | 3 | 2005 | 40 | 0.240 |
Why?
|
| RNA, Messenger | 6 | 2003 | 1265 | 0.240 |
Why?
|
| Liver | 9 | 1999 | 503 | 0.240 |
Why?
|
| Depression | 5 | 2003 | 837 | 0.230 |
Why?
|
| Metalloproteins | 6 | 1983 | 25 | 0.230 |
Why?
|
| Platelet Activation | 2 | 2003 | 6 | 0.230 |
Why?
|
| Monoamine Oxidase | 2 | 2006 | 36 | 0.220 |
Why?
|
| Platelet Count | 2 | 2006 | 12 | 0.220 |
Why?
|
| Harmine | 1 | 2003 | 4 | 0.210 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 1066 | 0.210 |
Why?
|
| Caudate Nucleus | 1 | 2003 | 22 | 0.210 |
Why?
|
| Hippocampus | 2 | 2013 | 591 | 0.210 |
Why?
|
| Psychiatry | 1 | 2003 | 35 | 0.200 |
Why?
|
| Frontal Lobe | 1 | 2003 | 58 | 0.200 |
Why?
|
| Alternative Splicing | 1 | 2003 | 92 | 0.200 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2006 | 15 | 0.200 |
Why?
|
| Cell Communication | 1 | 2003 | 110 | 0.200 |
Why?
|
| Animals, Newborn | 5 | 2013 | 350 | 0.200 |
Why?
|
| Exploratory Behavior | 1 | 2003 | 78 | 0.190 |
Why?
|
| Lactobacillus | 1 | 2022 | 22 | 0.190 |
Why?
|
| Immune Sera | 5 | 2000 | 56 | 0.190 |
Why?
|
| Amygdala | 1 | 2003 | 125 | 0.190 |
Why?
|
| Blood-Brain Barrier | 1 | 2003 | 167 | 0.190 |
Why?
|
| Glycols | 3 | 1990 | 7 | 0.180 |
Why?
|
| Tritium | 8 | 2000 | 51 | 0.180 |
Why?
|
| Neurons | 4 | 2003 | 1246 | 0.180 |
Why?
|
| Up-Regulation | 4 | 1998 | 534 | 0.180 |
Why?
|
| Membrane Fluidity | 2 | 1991 | 11 | 0.180 |
Why?
|
| Astrocytes | 1 | 2003 | 244 | 0.180 |
Why?
|
| Mice, Mutant Strains | 3 | 1987 | 85 | 0.180 |
Why?
|
| Circadian Rhythm | 3 | 1994 | 234 | 0.180 |
Why?
|
| Taraxacum | 1 | 2021 | 2 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 382 | 0.170 |
Why?
|
| Spinacia oleracea | 1 | 2021 | 8 | 0.170 |
Why?
|
| Menstrual Cycle | 2 | 1998 | 36 | 0.170 |
Why?
|
| Electric Impedance | 1 | 2021 | 28 | 0.170 |
Why?
|
| Caco-2 Cells | 1 | 2021 | 59 | 0.170 |
Why?
|
| P-Selectin | 1 | 2000 | 8 | 0.170 |
Why?
|
| Epithelium | 1 | 2021 | 78 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2013 | 2111 | 0.170 |
Why?
|
| Oxidopamine | 2 | 2005 | 23 | 0.170 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2000 | 42 | 0.170 |
Why?
|
| Peptides | 1 | 2003 | 357 | 0.170 |
Why?
|
| Tetracycline | 1 | 2020 | 17 | 0.170 |
Why?
|
| Biological Availability | 1 | 2021 | 115 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 1112 | 0.160 |
Why?
|
| Postmenopause | 1 | 2000 | 139 | 0.160 |
Why?
|
| Carboxy-Lyases | 3 | 2004 | 4 | 0.160 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2002 | 280 | 0.160 |
Why?
|
| Feces | 1 | 2020 | 126 | 0.160 |
Why?
|
| Integrins | 3 | 2003 | 54 | 0.160 |
Why?
|
| Macrophages | 1 | 2003 | 515 | 0.160 |
Why?
|
| Cholinergic Antagonists | 1 | 1999 | 10 | 0.160 |
Why?
|
| Cerebral Ventricles | 1 | 1999 | 23 | 0.160 |
Why?
|
| Dystonia | 1 | 1999 | 10 | 0.150 |
Why?
|
| Cell Membrane | 8 | 1997 | 400 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2021 | 134 | 0.150 |
Why?
|
| Enzyme Inhibitors | 4 | 2013 | 457 | 0.150 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 1999 | 81 | 0.150 |
Why?
|
| Milk | 4 | 1987 | 55 | 0.150 |
Why?
|
| Mice | 13 | 2003 | 6490 | 0.150 |
Why?
|
| Antipsychotic Agents | 1 | 1999 | 81 | 0.150 |
Why?
|
| Posture | 2 | 1997 | 61 | 0.140 |
Why?
|
| Binding, Competitive | 6 | 1999 | 107 | 0.140 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 1998 | 13 | 0.140 |
Why?
|
| CHO Cells | 4 | 2005 | 123 | 0.140 |
Why?
|
| Idazoxan | 4 | 2000 | 10 | 0.140 |
Why?
|
| Cricetinae | 4 | 2005 | 241 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2009 | 1586 | 0.140 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2598 | 0.140 |
Why?
|
| Stress, Psychological | 1 | 2003 | 641 | 0.130 |
Why?
|
| Aged, 80 and over | 6 | 2003 | 2803 | 0.130 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1997 | 8 | 0.130 |
Why?
|
| Orientation | 1 | 1997 | 31 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 506 | 0.130 |
Why?
|
| Blotting, Western | 5 | 2006 | 884 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 415 | 0.130 |
Why?
|
| Postural Balance | 1 | 1997 | 37 | 0.130 |
Why?
|
| Brain Stem | 1 | 1997 | 51 | 0.130 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 1996 | 4 | 0.130 |
Why?
|
| PC12 Cells | 5 | 2003 | 93 | 0.130 |
Why?
|
| Fluoxetine | 1 | 1996 | 15 | 0.130 |
Why?
|
| Time Factors | 4 | 2006 | 1848 | 0.130 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 1188 | 0.120 |
Why?
|
| Molecular Sequence Data | 4 | 2004 | 1559 | 0.120 |
Why?
|
| Aged | 8 | 2003 | 7982 | 0.110 |
Why?
|
| Hypotension | 2 | 2005 | 25 | 0.110 |
Why?
|
| Platelet Aggregation | 1 | 1993 | 21 | 0.100 |
Why?
|
| Affinity Labels | 3 | 2000 | 7 | 0.100 |
Why?
|
| Lactation | 3 | 1987 | 44 | 0.100 |
Why?
|
| Statistics as Topic | 2 | 2003 | 123 | 0.100 |
Why?
|
| Rabbits | 3 | 2005 | 292 | 0.100 |
Why?
|
| Personality Inventory | 2 | 2009 | 82 | 0.100 |
Why?
|
| Milk Proteins | 3 | 1981 | 29 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2013 | 85 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2013 | 124 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 1996 | 319 | 0.100 |
Why?
|
| Tissue Distribution | 1 | 2013 | 230 | 0.100 |
Why?
|
| Organ Culture Techniques | 1 | 2013 | 102 | 0.100 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 285 | 0.090 |
Why?
|
| Intracellular Membranes | 1 | 1991 | 37 | 0.090 |
Why?
|
| Cloning, Molecular | 4 | 2004 | 318 | 0.090 |
Why?
|
| Neurotoxins | 2 | 2003 | 55 | 0.090 |
Why?
|
| Cell Line | 3 | 2003 | 1416 | 0.090 |
Why?
|
| GTP-Binding Proteins | 3 | 1996 | 58 | 0.090 |
Why?
|
| Suicide | 2 | 2003 | 139 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2005 | 458 | 0.080 |
Why?
|
| Chromatography, Gas | 1 | 1989 | 16 | 0.080 |
Why?
|
| COS Cells | 4 | 2004 | 67 | 0.080 |
Why?
|
| Molecular Weight | 3 | 2003 | 168 | 0.080 |
Why?
|
| Animals, Suckling | 2 | 1987 | 11 | 0.080 |
Why?
|
| Immunoblotting | 3 | 2003 | 181 | 0.080 |
Why?
|
| Naphazoline | 2 | 2000 | 2 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 421 | 0.070 |
Why?
|
| Organ Specificity | 2 | 1999 | 141 | 0.070 |
Why?
|
| Neurotransmitter Agents | 2 | 2003 | 69 | 0.070 |
Why?
|
| Cattle | 4 | 1998 | 505 | 0.070 |
Why?
|
| Transfection | 4 | 2004 | 526 | 0.070 |
Why?
|
| Copper | 2 | 1987 | 134 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2003 | 1804 | 0.070 |
Why?
|
| Dizocilpine Maleate | 2 | 2005 | 43 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 727 | 0.070 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2006 | 7 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 1986 | 17 | 0.060 |
Why?
|
| Subcellular Fractions | 2 | 2003 | 79 | 0.060 |
Why?
|
| Mice, Inbred C3H | 2 | 1983 | 80 | 0.060 |
Why?
|
| Ganglionic Stimulants | 1 | 2006 | 2 | 0.060 |
Why?
|
| Tobacco, Smokeless | 1 | 2006 | 19 | 0.060 |
Why?
|
| Locus Coeruleus | 1 | 2006 | 15 | 0.060 |
Why?
|
| Autoradiography | 2 | 2003 | 35 | 0.060 |
Why?
|
| Receptors, Adrenergic | 1 | 1985 | 11 | 0.060 |
Why?
|
| Morphine | 1 | 2005 | 68 | 0.060 |
Why?
|
| Mice, Inbred Strains | 2 | 1981 | 116 | 0.060 |
Why?
|
| Adolescent | 3 | 2000 | 5950 | 0.050 |
Why?
|
| Kinetics | 3 | 1996 | 698 | 0.050 |
Why?
|
| Injections, Intraventricular | 2 | 2005 | 59 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 1991 | 972 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 30 | 0.050 |
Why?
|
| Cold Temperature | 1 | 2003 | 41 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2003 | 93 | 0.050 |
Why?
|
| Cadmium Poisoning | 1 | 1983 | 2 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1983 | 8 | 0.050 |
Why?
|
| Exons | 1 | 2003 | 91 | 0.050 |
Why?
|
| Arginine | 1 | 2003 | 75 | 0.050 |
Why?
|
| Cytoskeleton | 1 | 2003 | 111 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2003 | 139 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 1983 | 72 | 0.050 |
Why?
|
| Guanabenz | 1 | 2003 | 3 | 0.050 |
Why?
|
| Biological Transport | 1 | 2003 | 201 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 169 | 0.050 |
Why?
|
| Epitopes | 1 | 2003 | 155 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 128 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 136 | 0.050 |
Why?
|
| Nervous System Diseases | 1 | 2003 | 76 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2004 | 149 | 0.050 |
Why?
|
| Protein Binding | 2 | 2003 | 1076 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2003 | 108 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 133 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 156 | 0.050 |
Why?
|
| Benzazepines | 1 | 2003 | 33 | 0.050 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2003 | 110 | 0.050 |
Why?
|
| Sympathetic Nervous System | 1 | 2003 | 64 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2003 | 487 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2003 | 235 | 0.050 |
Why?
|
| Genetic Variation | 2 | 1981 | 429 | 0.050 |
Why?
|
| Diphenylhexatriene | 2 | 1991 | 2 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2003 | 560 | 0.050 |
Why?
|
| Fetus | 4 | 2003 | 101 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 2000 | 62 | 0.040 |
Why?
|
| Sequence Tagged Sites | 1 | 2000 | 4 | 0.040 |
Why?
|
| Ruthenium Red | 1 | 2000 | 4 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2002 | 201 | 0.040 |
Why?
|
| Menopause | 1 | 2000 | 63 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 206 | 0.040 |
Why?
|
| Cell Survival | 1 | 2003 | 934 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2000 | 106 | 0.040 |
Why?
|
| Mitochondria | 1 | 2003 | 516 | 0.040 |
Why?
|
| Cytokines | 1 | 2003 | 661 | 0.040 |
Why?
|
| Staurosporine | 3 | 2003 | 38 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1999 | 29 | 0.040 |
Why?
|
| Cloning, Organism | 1 | 1999 | 22 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2002 | 381 | 0.040 |
Why?
|
| Acrodermatitis | 1 | 1979 | 4 | 0.040 |
Why?
|
| Cell Count | 1 | 1999 | 140 | 0.040 |
Why?
|
| Apoptosis | 2 | 2003 | 1541 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 1998 | 68 | 0.040 |
Why?
|
| Gene Library | 1 | 1998 | 60 | 0.040 |
Why?
|
| Spleen | 1 | 1999 | 199 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 134 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1998 | 12 | 0.040 |
Why?
|
| Testis | 1 | 1999 | 203 | 0.030 |
Why?
|
| Electrochemistry | 1 | 1998 | 38 | 0.030 |
Why?
|
| Pregnancy | 5 | 1987 | 1737 | 0.030 |
Why?
|
| Young Adult | 1 | 2009 | 4936 | 0.030 |
Why?
|
| Oxazoles | 1 | 1997 | 19 | 0.030 |
Why?
|
| Base Sequence | 2 | 1998 | 997 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 1999 | 638 | 0.030 |
Why?
|
| o-Phthalaldehyde | 1 | 1997 | 4 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 1995 | 1617 | 0.030 |
Why?
|
| Biperiden | 1 | 1997 | 1 | 0.030 |
Why?
|
| Nortriptyline | 1 | 1997 | 1 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1997 | 59 | 0.030 |
Why?
|
| Maprotiline | 1 | 1997 | 3 | 0.030 |
Why?
|
| Amitriptyline | 1 | 1997 | 9 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1996 | 7 | 0.030 |
Why?
|
| Phencyclidine | 1 | 1996 | 19 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 308 | 0.030 |
Why?
|
| Kidney | 1 | 1999 | 363 | 0.030 |
Why?
|
| Olfactory Bulb | 1 | 1997 | 50 | 0.030 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 184 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 1997 | 233 | 0.030 |
Why?
|
| Lung | 1 | 1999 | 484 | 0.030 |
Why?
|
| Hypertension | 1 | 2003 | 823 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 602 | 0.030 |
Why?
|
| Ligands | 2 | 1991 | 387 | 0.030 |
Why?
|
| Cohort Studies | 1 | 1999 | 1729 | 0.030 |
Why?
|
| Dioxanes | 1 | 1993 | 11 | 0.030 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1994 | 27 | 0.030 |
Why?
|
| Premenstrual Syndrome | 1 | 1993 | 13 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 2 | 2003 | 44 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2000 | 2485 | 0.030 |
Why?
|
| Catecholamines | 1 | 1993 | 45 | 0.030 |
Why?
|
| Morpholines | 2 | 2003 | 73 | 0.030 |
Why?
|
| Chromones | 2 | 2003 | 53 | 0.030 |
Why?
|
| Caspases | 2 | 2003 | 148 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2003 | 226 | 0.020 |
Why?
|
| Cell Death | 2 | 2003 | 277 | 0.020 |
Why?
|
| Osmolar Concentration | 2 | 1995 | 53 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1992 | 24 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1992 | 53 | 0.020 |
Why?
|
| Fluorescence Polarization | 1 | 1991 | 28 | 0.020 |
Why?
|
| Fluorescence | 1 | 1991 | 113 | 0.020 |
Why?
|
| Species Specificity | 2 | 1983 | 279 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 1990 | 45 | 0.020 |
Why?
|
| Affect | 1 | 1992 | 177 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1989 | 61 | 0.020 |
Why?
|
| Models, Statistical | 1 | 1990 | 190 | 0.020 |
Why?
|
| Cognition | 1 | 1992 | 458 | 0.020 |
Why?
|
| Animals, Wild | 1 | 1987 | 24 | 0.020 |
Why?
|
| Micelles | 1 | 1987 | 36 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1986 | 27 | 0.020 |
Why?
|
| Models, Biological | 1 | 1990 | 711 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1983 | 132 | 0.020 |
Why?
|
| Cell Separation | 1 | 1986 | 94 | 0.020 |
Why?
|
| Cadmium | 2 | 1983 | 54 | 0.020 |
Why?
|
| Chemistry | 1 | 1986 | 15 | 0.020 |
Why?
|
| Filtration | 1 | 1986 | 17 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1989 | 1058 | 0.020 |
Why?
|
| Glass | 1 | 1986 | 19 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 1986 | 56 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1987 | 131 | 0.020 |
Why?
|
| Nifedipine | 1 | 2005 | 11 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2005 | 36 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1987 | 237 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 88 | 0.010 |
Why?
|
| Naloxone | 1 | 2005 | 56 | 0.010 |
Why?
|
| Gestational Age | 2 | 1983 | 195 | 0.010 |
Why?
|
| Hydrocortisone | 2 | 1983 | 89 | 0.010 |
Why?
|
| Imidazolines | 1 | 2005 | 1 | 0.010 |
Why?
|
| 5,6-Dihydroxytryptamine | 1 | 2005 | 2 | 0.010 |
Why?
|
| Serotonin Agents | 1 | 2005 | 3 | 0.010 |
Why?
|
| Adrenergic Agents | 1 | 2005 | 8 | 0.010 |
Why?
|
| Bradycardia | 1 | 2005 | 9 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 2005 | 135 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2005 | 54 | 0.010 |
Why?
|
| Research Design | 1 | 1986 | 370 | 0.010 |
Why?
|
| Serotonin | 1 | 2005 | 125 | 0.010 |
Why?
|
| Ornithine Decarboxylase | 1 | 2004 | 10 | 0.010 |
Why?
|
| DNA Probes | 1 | 2004 | 33 | 0.010 |
Why?
|
| Integrin alpha5beta1 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Dopamine | 1 | 2006 | 272 | 0.010 |
Why?
|
| Calcimycin | 1 | 2003 | 11 | 0.010 |
Why?
|
| Ionophores | 1 | 2003 | 11 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2003 | 26 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2003 | 8 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 27 | 0.010 |
Why?
|
| Androstadienes | 1 | 2003 | 19 | 0.010 |
Why?
|
| Anilides | 1 | 2003 | 28 | 0.010 |
Why?
|
| N-Methylaspartate | 1 | 2003 | 58 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 64 | 0.010 |
Why?
|
| Adrenalectomy | 1 | 1983 | 23 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 273 | 0.010 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1983 | 22 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2003 | 100 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 314 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2003 | 108 | 0.010 |
Why?
|
| Nicotine | 1 | 2006 | 290 | 0.010 |
Why?
|
| Flavonoids | 1 | 2003 | 94 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2003 | 131 | 0.010 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2002 | 8 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2003 | 159 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 51 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 167 | 0.010 |
Why?
|
| Metals | 1 | 1983 | 113 | 0.010 |
Why?
|
| Immunoelectrophoresis | 1 | 1981 | 3 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 411 | 0.010 |
Why?
|
| Lactose | 1 | 1981 | 16 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2002 | 23 | 0.010 |
Why?
|
| Trypsin | 1 | 1981 | 40 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1981 | 32 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 383 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 119 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1981 | 37 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 303 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1981 | 198 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 247 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 427 | 0.010 |
Why?
|
| Amino Acids | 1 | 1981 | 150 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2002 | 279 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 740 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1981 | 301 | 0.010 |
Why?
|
| Age Factors | 1 | 1982 | 1139 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 973 | 0.010 |
Why?
|
| Milk, Human | 1 | 1979 | 51 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1996 | 282 | 0.010 |
Why?
|
| Luteal Phase | 1 | 1993 | 6 | 0.010 |
Why?
|
| Follicular Phase | 1 | 1993 | 5 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1989 | 156 | 0.000 |
Why?
|
| Genes | 1 | 1983 | 56 | 0.000 |
Why?
|
| Cadmium Chloride | 1 | 1983 | 10 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1983 | 136 | 0.000 |
Why?
|
| DNA | 1 | 1983 | 594 | 0.000 |
Why?
|